Virginia Commonwealth University
Richmond, Virginia, 23219, United States
NCT Number: NCT02755181
This study aims to use resting-state and task based functional Magnetic Resonance Imaging (fMRI) as a tool to evaluate trait characteristics of impulsivity in subjects with borderline personality disorder.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Observational
Richmond, Virginia, 23219, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All Participants:
In addition, Healthy Controls excluded, if:
In addition, Borderline Personality Disorder Subjects excluded if:
with functional imaging and behavioural measurements at baseline and 4 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Time frame: up to 5 weeks
Boehringer Ingelheim
Industry
Assessment of Longitudinal Functional Magnetic Resonance Imaging (fMRI) as a Brain Measure for Impulsivity in a Borderline Personality Disorder (BPD) Model
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03887429
Behavior, Disruptive, Impulse Control, and Conduct Disorders
Lincoln, Nebraska, United States
View Trial DetailsNCT02722174
Disruptive, Impulse Control, and Conduct Disorders, Impulse Control Disorders
Richmond, Virginia, United States
View Trial DetailsNCT02319395
Basal Ganglia Diseases, Brain Diseases
Paris, France
View Trial DetailsNCT00118014
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Charlestown, Massachusetts, United States
View Trial Details